Salts of methyl (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-A]pyrazine-1-carboxylate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8618104
APP PUB NO 20120122875A1
SERIAL NO

13322142

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The pharmaceutically acceptable salts of methyl (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1-carboxylate, their preparation methods and their use for preparing anti-diabetic medicaments are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JIANGSU HENGRUI MEDICINE CO LTD222047 NO 7 KUNLUN MOUNTAIN ROAD LIANYUNGANG ECONOMIC AND TECHNOLOGICAL DEVELOPMENT ZONE JIANGSU LIANYUNGANG CITY JIANGSU PROVINCE 222047

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liu, Huawen Lianyungang Jiangsu, CN 1 0
Ma, Shuqin Lianyungang Jiangsu, CN 3 0
Yuan, Kaihon Lianyungang Jiangsu, CN 1 0
Zhu, Lin Lianyungang Jiangsu, CN 183 1022

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 30, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00